- Home
- MEDP vs CX Comparison
MEDP vs CX Comparison
Compare MEDP & CX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- CX
- Stock Information
- Founded
- MEDP 1992
- CX 1906
- Country
- MEDP United States
- CX Mexico
- Employees
- MEDP N/A
- CX N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- CX Building Materials
- Sector
- MEDP Health Care
- CX Industrials
- Exchange
- MEDP Nasdaq
- CX Nasdaq
- Market Cap
- MEDP 13.4B
- CX 12.2B
- IPO Year
- MEDP 2016
- CX 1999
- Fundamental
- Price
- MEDP $584.91
- CX $10.15
- Analyst Decision
- MEDP Hold
- CX Buy
- Analyst Count
- MEDP 11
- CX 7
- Target Price
- MEDP $451.70
- CX $10.52
- AVG Volume (30 Days)
- MEDP 354.5K
- CX 10.7M
- Earning Date
- MEDP 10-22-2025
- CX 10-28-2025
- Dividend Yield
- MEDP N/A
- CX 0.85%
- EPS Growth
- MEDP 25.36
- CX 293.85
- EPS
- MEDP 14.32
- CX 0.09
- Revenue
- MEDP $2,358,373,000.00
- CX $15,869,840,000.00
- Revenue This Year
- MEDP $19.15
- CX $2.64
- Revenue Next Year
- MEDP $8.91
- CX $4.82
- P/E Ratio
- MEDP $40.85
- CX $10.80
- Revenue Growth
- MEDP 13.88
- CX N/A
- 52 Week Low
- MEDP $250.05
- CX $4.89
- 52 Week High
- MEDP $625.00
- CX $10.45
- Technical
- Relative Strength Index (RSI)
- MEDP 66.03
- CX 66.14
- Support Level
- MEDP $571.03
- CX $10.10
- Resistance Level
- MEDP $595.00
- CX $10.45
- Average True Range (ATR)
- MEDP 19.57
- CX 0.28
- MACD
- MEDP 2.23
- CX 0.08
- Stochastic Oscillator
- MEDP 65.10
- CX 77.70
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About CX Cemex S.A.B. de C.V. Sponsored ADR
Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and also provide related services and reliable construction-related services to customers and communities and maintain business relationships in more than 60 countries throughout the world. The company operates in different parts of the world, with operations in Mexico, the United States, the EMEA region and the SCA&C region.